Live feed13:45:00·1333dPRReleasevia QuantisnowVeru Announces Date for FDA Advisory Committee Meeting to Review Emergency Use Authorization for Sabizabulin for Hospitalized COVID-19 Patients at High Risk for Acute Respiratory Distress SyndromeByQuantisnow·Wall Street's wire, on your screen.VERU· Veru Inc.Health Care
